Amerinet Partners With Covis Pharmaceuticals for Brand-Name Medications

Amerinet, a national healthcare solutions organization, has announced it has signed an agreement with Covis Pharmaceuticals for a variety of specialty name-brand medications, according to a news release from Amerinet.

Advertisement

 

The agreement, effective through Jan. 31, 2015, offers Amerinet members savings on a variety of leading pharmaceutical products including Lanoxin (digoxin), Fortaz (ceftazidime), Zinacef (cefuroxime) and Zantac Injection (ranitidine hydrochloride).

 

View all new Amerinet agreements.

 

More Articles Featuring Amerinet:

12 Critical Concepts to Know About ASC Supplies and Contracts

Amerinet Partners With Acacia Neonatal for NICU Products

Amerinet Partners With Hamilton Medical on Ventilators

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.